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INTRODUCTION
The incidence of skin cancer is increasing worldwide (1-
3). Non-melanoma skin cancers (NMSCs) constitute more
than one-third of all cancers in USA with an estimated inci-
dence of over 600,000 cases per year. The NMSCs are the
most common malignancies occurring in the white popula-
tion (3). The incidence of melanoma is much lower than that
of NMSCs; but it is the most rapidly increasing cancer in the
white population (3). Meanwhile, the incidence of skin can-
cers in Asians was thought to be relatively low compared to
Caucasians. However, a number of epidemiologic studies
from Korea and Japan show a gradual increase in incidence
of skin cancers in East Asia (4-12). 
Although a number of reports have been made on the inci-
dence of premalignant and malignant skin lesions in Korea,
most had limitation in terms of patient number and location
(i.e, based a single hospital) (5-12). To observe the recent trend
in the incidence of cutaneous premalignant and malignant
lesions in Korea, we investigated 571,057 dermatology out-
patients from 8 affiliated university hospitals in Korea through
1991 to 2006. This is the largest hospital-based survey made
on cutaneous premalignant and malignant lesions in Korea.
MATERIALS AND METHODS 
The dermatology outpatient department of 8 affiliated uni-
versity hospitals in Korea participated in this study. Three
hospitals are located in Seoul, 4 in Gyeonggi-do Province
(Uijeongbu, Bucheon, Bupyeong and Suwon), and one in Dae-
jeon. This research was approved by the Institutional Review
Board (IRB) of Seoul St. Mary’s Hospital.
Incident cases of melanoma, NMSCs and premalignant
skin lesions, newly diagnosed in the hospitals between Jan-
uary 1, 1991 and December 31, 2006, were identified by
reviewing the patients’ medical record. The primary outcome
measures were the dermatology outpatient-based incidence
values of premalignant and malignant skin lesions during the
16-yr period and the change in their incidence over 2 consec-
utive periods (1991-1998 and 1999-2006). The proportion
of an individual skin lesion (actinic keratosis [AK], Bowen’s
disease [BD], basal cell carcinoma [BCC], squamous cell car-
cinoma [SCC] and melanoma) among the respective prema-
lignant or malignant skin lesions was calculated over the 16
yr period as well as the 2 consecutive 8-yr periods. In addi-
tion, the patients’ distribution in terms of age, sex and the
anatomical location of the premalignant and malignant skin
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Recent Trend in the Incidence of Premalignant and Malignant Skin
Lesions in Korea between 1991 and 2006
We evaluated the recent trend in the incidence of premalignant and malignant skin
lesions between 1991 and 2006. Among 571,057 newly registered dermatology
out-patients from our 8 affiliated university hospitals, 2,598 were diagnosed with a
premalignant (899, 0.16%) or malignant skin lesions (1,699, 0.30%). Of 899 pre-
malignant cases, 71.2% were actinic keratosis (AK), and 24.6% were Bowen’s dis-
ease. Of 1,699 malignant cases, 46.2% were basal cell carcinoma, followed by
squamous cell carcinoma (19.1%) and melanoma (7.1%). This 16-yr survey was
divided equally into two time periods to compare the incidence of premalignant and
malignant skin lesions at different time settings. Between 1991 and 1998, the inci-
dence of cutaneous premalignancy was 0.10% which doubled during 1999-2006.
For cutaneous malignancy, the incidence was 0.25% during 1991-1998 and 0.34%
in 1999-2006. Incidence of AK among the new outpatients was 0.07% in 1991-1998
which staggered up to 0.15% in 1999-2006. These findings show an increase of
both premalignant and malignant skin lesions, AK in particular in the dermatology
outpatient-based incidence. 
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lesions was calculated for the period of diagnosis (1991-2006). 
RESULTS
Among 571,057 newly registered outpatients (1991-2006)
from the 8 affiliated university hospitals, 2,598 were diag-
nosed with either premalignant (899, 0.16%) or malignant
skin lesions (1,699, 0.30%). We divided the 16-yr study
period into two equal intervals (1991-1998 and 1999-2006)
to compare the incidence of premalignant and malignant
skin lesions among dermatology outpatients over time. The
incidence of cutaneous premalignancies rose from 0.10% to
0.20% while that of malignant skin lesions rose from 0.25%
to 0.34%. As for the individual disease entity, the incidence
of AK among the dermatology outpatients was 0.11% (1991-
2006), 0.07% (1991-1998) and 0.15% (1999-2006), respec-
tively. The incidence of BD was 0.04% (1991-2006), 0.03%
(1991-1998) and 0.05% (1999-2006). The overall incidence
of BCC was 0.14% with 0.12% in the former 8 yr and 0.15%
in the latter 8 yr. The incidence for SCC were 0.06% (1991-
2006), 0.05% (1991-1998) and 0.06% (1999-2006), and
for melanoma, 0.02% (1991-2006), 0.02% (1991-1998) and
0.03% (1999-2006) (Table 1, Fig. 1). The proportion of each
of the major premalignant (AK, BD) and malignant skin
lesion (BCC, SCC, melanoma) out of the respective prema-
lignant and malignant cases were presented in Figs. 2, 3, over
the whole 16 yr as well as the two consecutive 8 yr periods. 
For both premalignant and malignant skin lesions, females
The percentage (%) of cases
with premalignant skin
lesions out of total new out-
patients in the dermatology
department
No. of newly
registered
dermatology
outpatients
Province Authors Period
Total AK BD
The percentage (%) of cases with
malignant skin lesions out of total 
new outpatients in the dermatology 
department
Total BCC SCC Melanoma
Our case Seoul, 
Gyeonggi province, 
Chungcheong province
1991-1998 258,452 0.10 0.07 0.03 0.25 0.12 0.05 0.02
1999-2006 312,605 0.20 0.15 0.05 0.34 0.15 0.06 0.03
1991-2006 571,057 0.16 0.11 0.04 0.30 0.14 0.06 0.02
Chung et al. (5) Seoul
1982-1986 65,002 0.03 0.13
1987-1991 67,024 0.06 0.19
1991-1996 59,142 0.11 0.36
1982-1996 191,168 0.06 0.03 0.03 0.22 0.09 0.05 0.01
Shin et al. (6) Seoul
1984-1990 140,899 0.05
1991-1998 67,484 0.14
1984-1998 208,383 0.09 0.04 0.02 0.01
Jeong et al. (9) 1990-2000 Daegu 34,333 0.12 0.06 0.06 0.39 0.16 0.12 0.01
Moon et al. (8) 1990-1995 Seoul 20,175 0.50 0.41 0.08 1.02 0.25 0.13 0.54
Seo et al. (10) 1996-2000 Seoul 23,193 0.40 0.27 0.13 1.02 0.23 0.20 0.13
Kim et al. (11) 2001-2005 Seoul 23,971 0.52 0.38 0.15 1.08 0.46 0.21 0.12
Chun et al. (12) 1987-2006 Gwangju city and  97,130 1.47 0.87 0.26 0.15
Chonnam province
Table 1. The incidence of the premalignant and malignant skin lesions out of the total number of new dermatology outpatients
AK, actinic keratosis; BD, Bowen’s disease; BCC, basal cell carcinoma; SCC, squamous cell carcinoma.
Fig. 1. The incidence of actinic keratosis (AK), Bowen’s disease
(BD), basal cell carcinoma (BCC), squamous cell carcionoma
(SCC) and melanoma between 2 consecutive time periods (1991-
1998, 1999-2006).
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outnumbered the male population (66.9% vs. 33.1% and
52.5% vs. 47.5%, respectively) (1991-2006). The female to
male ratio of the individual disease were 2.9 for AK, 1.2 for
BD, 1.1 for BCC, 1.4 for SCC and 0.9 for melanoma.
The age distribution of the individual skin lesion was exam-
ined. AK and SCC were most prevalent between the ages 71
and 80, and patients were most common in the 61-70 age
group over the whole 16 yr for BD, BCC and melanoma.
There was little difference in the peak age of the individual
skin lesion between the former and latter 8 yr.
In terms of anatomical distribution, 73.4% of premalig-
nant and 63.2% of malignant skin lesions occurred on the
head and neck area, followed by the trunk (15.2% vs. 20.1%)
and extremities (11.5% vs. 16.7%) (Figs. 4, 5). Within the
head and neck area, the cheek was the most prevalent site
for the premalignant lesion to appear (46.2%), followed by
the forehead (15.5%), nose (10.0%), periorbital area (9.0%),
lower lip (6.0%) and so on (Fig. 6). Within the head and neck,
the nose was most commonly affected by a malignant skin
lesion followed by the cheek (21.0%), periorbital area (13.8%),
scalp (13.2%), and forehead (8.0%) (Fig. 7). For the individ-
ual disease entity, 94.7% of AK developed on the head and
Fig. 2. The proportion of the major premalignant skin lesions over time.
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Fig. 3. The proportion of the major malignant skin lesions over time.
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Fig. 4. The proportion of the premalignant skin lesions according
to body location.
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neck area, mostly on the cheek (43.7%), followed by the nose
(10.1%), forehead (15.0%), periorbital area (8.3%), lip (6.9
%), ear (4.6%), chin (2.0%), and neck (1.1%). 75.8% of BDs
occurred on the trunk and extremities, especially on the legs
(20.2%), followed by the hands and fingers (8.1%), back (9.0
%), arm (4.0%), abdomen (7.6%), chest (7.6%), buttock (4.5
%), genitalia (10.8%) and anus (1.4%). Among malignant
tumors, 91.2% of BCCs and 70.6% of SCCs developed on
the head and neck area. For BCCs, the nose was the most pre-
valent site (34.6%), followed by the cheek (15.9%), perior-
bital area (17.0%), scalp (7.5%), forehead (6.8%), ears (4.7%),
lip (1.9%), neck (1.6%), and chin (1.3%). In SCCs, the cheek
was the most prevalent site (22.3%), followed by the scalp
(9.3%), lip (9.9%), nose (7.1%), forehead (7.1%), ears (6.8%),
chin (3.1%), periorbital area (2.5%), and neck (2.2%). Mela-
noma preferred the extremities (66.9%), especially the feet
(24.0%), followed by the fingers (12.4%), legs (10.7%), toes
(8.3%), arms (8.3%), and hands (3.3%).
DISCUSSION
Based on the clinical records of dermatology outpatients
from 8 affiliated university hospitals, a total of 571,057 cases
were retrospectively reviewed. We believe this is the largest
hospital-based study for premalignant and malignant skin
lesions in Korea. The percentage of patients diagnosed with
a premalignant skin lesion among the newcomers in the der-
matology department was 0.10% during 1991-1998 but rose
to 0.20% in 1999-2006. For malignant skin lesions, the in-
cidence was 0.25% and 0.34%, respectively. Chung et al. (5)
performed a similar study from 1982 to 1996 on both pre-
malignant and malignant skin disease. The incidence of the
premalignant skin lesions was 0.03% (1982-1986), 0.06%
(1987-1991) and 0.11% (1991-1997) whereas that of the
malignant skin lesions was 0.13% (1982-1986), 0.19% (1987-
1991) and 0.36% (1991-1997). The incidence of premalig-
nant skin lesions during 1991-1998 in our case (0.10%) was
similar to that of Chung et al. (5) (1991-1997, 0.11%), but
for cutaneous malignancies, our values were slightly lower
(0.25% vs. 0.36%). However, in another study (6), the inci-
dence of cutaneous malignancies during 1991-1998 was
0.14% which was lower than ours. A number of studies were
performed from a single university hospital in Seoul at differ-
ent time settings (8, 10, 11) where the reported incidence of
both the premalignant and malignant skin lesions were sub-
stantially higher (premalignant, 0.50%; malignant, 1.02%,
Fig. 5. The proportion of the malignant skin lesions according to
body location.
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Fig. 6. Distribution of the premalignant skin lesions within the head and neck area.
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1990-1995) than others. In this particular hospital, severe
disease is manifested in a large proportion of patients and this
likely have attributed to the findings. A recent study from a
university hospital in Gwangju city and Chonnam province
reported a similarly high incidence of malignant skin lesions
as well (12). Based on the data from previous studies (5-12)
and ours, the incidence of the premalignant and malignant
skin lesions seem to be in a continuous rise since the early
1980s. As for the incidence of an individual lesion, AK show-
ed a sharp increase compared to others (BD, BCC, SCC, and
melanoma). There was a subtle increase in BCC and BD, whe-
reas the incidence of SCC and melanoma were fairly constant.
It was assumed that the early detection of skin cancer in the
so called pre-SCC stage (AK, BD) and proper management
of burn scars or skin tuberculosis suppressed the rise in the
incidence of SCC.
The ratio between the premalignant and malignant skin
lesions was 29.3%/70.7% in 1991-1998 and 37.5%/62.5%
in 1999-2006. The increase in the proportion of cutaneous
premalignancies was a consistent trend in all of 8 affiliated
hospitals (data not shown). AK (71.2% of all premalignan-
cies) and BD (24.6%) were the two most common prema-
lignant skin lesions whereas for skin cancers, BCC (46.2% of
all malignancies), SCC (19.1%), metastatic cancer and mela-
noma (7.1%) were common in a decreasing order. In our study,
the change in the proportion of 2 major premalignant (AK,
BD) and 3 major malignant skin lesion (BCC, SCC, melano-
ma) over their respective premalignant and malignant lesions
was calculated over 2 different time periods (1991-1998,
1999-2006) for comparison. Among the premalignancies,
only AK showed an increase in its proportion over time. The
increase in the proportion of AK reflects increased UV expo-
sure as well as a better understanding of skin cancer in gen-
eral population. The increase in cancer surveillance and early
detection is likely a result of increased public relations on
skin cancer. 
The proportion of BD was about one third of that of AK,
and decreased over time. This may be explained by the fact
that BD is not associated with solar radiation. In addition,
arsenicals, which has been major cause of BD in the past, is
now banned from Korean herbal medication.
The incidence of BCC increased with negligible decrease
in its proportion among the malignant skin lesions in the
later 8 yr (1999-2006) compared to the former half (1991-
1998). BCC proved to be the most prevalent form of skin
cancer. The ratio of BCC to SCC increased over time; 2.4 in
1991-1998 and 2.5 in 1999-2006. SCC used to be the most
common of skin cancer in Korea, but the trend changed. BCC
became the most prevalent type since the 1990s. BCC is now
universally accepted as the most common form of skin can-
cer worldwide.
During this study period (1991-2006), for both premalig-
nant and malignant skin lesions, females outnumbered males
(66.9% vs. 33.1% and 52.5% vs. 47.5% respectively). In pre-
vious reports, males generally outnumbered females for cuta-
neous malignancies whereas there was slight predominance
of females for cutaneous premalignancies (5, 8-11). The recent
increased proportion of women with skin cancer is probably
due to increased UV exposure and their longer life-span com-
pared to men. 
In AK, BD, and BCC, the peak age group was 61-80 yr.
However, when the values between the two 8 yr-period were
compared, a higher proportion of patients in the latter 8 yr
were in the older age group. The peak age group of SCC was
slightly higher, ranging from 71-90 yr. A relatively even age
distribution was seen in melanoma. The longer life span and
frequent hospital visits in the elderly have likely contribut-
ed to the increase in patients’ age. It is nevertheless natural
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that the elderly have higher incidence of skin cancer with the
accumulated exposure to UV and deteriorated innate protec-
tive means of the skin. The age distribution of premalignant
and malignant skin lesions in this study was slightly higher
compared to those performed in the 1980s (5-12).
In terms of anatomical location, 73.4% of the premalignant
and 63.2% of all malignant skin lesions were found on the
head and neck followed by the trunk and extremities. With-
in the head and neck, a majority of the premalignant lesions
developed on the cheek, followed by the forehead, nose and
periorbital area. The nose was the most common site of in-
volvement within the head and neck area by a malignant skin
lesion followed by the cheek, periorbital area and scalp. The
location of AK, BD, BCC, SCC and melanoma was fairly sim-
ilar to those previously reported.
The limitation of this study is that it is retrospective. Beca-
use we were not able to standardize our patients to the Korean
standard population, our data did not represent the incidence
or trend of premalignant and malignant skin lesions in Korea.
A large scale study conducted prospectively in randomly select-
ed multi-centers will be warranted.
In conclusion, data of this study showed an increased inci-
dence of both premalignant and malignant skin lesions, with
AK in particular. Skin cancer prevention by sunscreen and
early detection should be emphasized.
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